Quinazolinones as prolyl hydroxylase inhibitors

Details for Australian Patent Application No. 2010213814 (hide)

Owner Janssen Pharmaceutica NV

Inventors Bembenek, Scott D.; Hocutt, Frances M.; Leonard Jr., Barry Eastman; Rosen, Mark D.; Tarantino, Kyle T.; Rabinowitz, Michael H.; Venkatesan, Hiriharan

Agent Shelston IP

Pub. Number AU-A-2010213814

PCT Pub. Number WO2010/093727

Priority 61/151,429 10.02.09 US

Filing date 10 February 2010

Wipo publication date 19 August 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/093727 Priority application(s): WO2010/093727

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010213822-Wellbore servicing fluids comprising cationic polymers and methods of using same

2010213807-Systems and methods for delivering neural therapy correlated with patient status